» Articles » PMID: 16584155

Use of Hydrophilic Natural Gums in Formulation of Sustained-release Matrix Tablets of Tramadol Hydrochloride

Overview
Publisher Springer
Specialty Pharmacology
Date 2006 Apr 6
PMID 16584155
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this work was to develop matrix sustained-release tablets of highly water-soluble tramadol HCl using natural gums (xanthan [X gum] and guar [G gum]) as cost-effective, nontoxic, easily available, and suitable hydrophilic matrix systems compared with the extensively investigated hydrophilic matrices (ie, hydroxypropyl methylcellulose [HPMC]/carboxymethyl cellulose [CMC] with respect to in vitro drug release rate) and hydration rate of the polymers. Matrix tablets of tramadol (dose 100 mg) were produced by direct compression method. Different ratios of 100:0, 80:20, 60:40, 20:80, 0:100 of G gum (or X):HPMC, X gum:G gum, and triple mixture of these polymers (G gum, X gum, HPMC) were applied. After evaluation of physical characteristics of tablets, the dissolution test was performed in the phosphate buffer media (pH 7.4) up to 8 hours. Tablets with only X had the highest mean dissolution time (MDT), the least dissolution efficiency (DE(8)%), and released the drug following a zero-order model via swelling, diffusion, and erosion mechanisms. Guar gum alone could not efficiently control the drug release, while X and all combinations of natural gums with HPMC could retard tramadol HCl release. However, according to the similarity factor (f(2) ), pure HPMC and H(8)G(2) were the most similar formulations to Topalgic-LP as the reference standard.

Citing Articles

Synthesis of a PVA drug delivery system for controlled release of a Tramadol-Dexketoprofen combination.

Flores-Arriaga J, Chavarria-Bolanos D, de Jesus Pozos-Guillen A, Escobar-Barrios V, Cerda-Cristerna B J Mater Sci Mater Med. 2021; 32(5):56.

PMID: 33961138 PMC: 8105240. DOI: 10.1007/s10856-021-06529-3.


Hybrid polymeric matrices for oral modified release of Desvenlafaxine succinate tablets.

Samy W, Elnoby A, El-Gowelli H, Elgindy N Saudi Pharm J. 2017; 25(5):676-687.

PMID: 28725139 PMC: 5506642. DOI: 10.1016/j.jsps.2016.10.005.


Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery.

Nath B, Nath L J Pharm (Cairo). 2015; 2013:546324.

PMID: 26555985 PMC: 4595939. DOI: 10.1155/2013/546324.


Isolation, characterization, and evaluation of Cassia fistula Linn. seed and pulp polymer for pharmaceutical application.

Killedar S, Nale A, More H, Nadaf S, Pawar A, Tamboli U Int J Pharm Investig. 2014; 4(4):215-25.

PMID: 25426443 PMC: 4241627. DOI: 10.4103/2230-973X.143128.


Formulation and In Vitro Evaluation of Ofloxacin Tablets using Natural Gums as Binders.

Mistry A, Nagda C, Nagda D, Dixit B, Dixit R Sci Pharm. 2014; 82(2):441-8.

PMID: 24959411 PMC: 4065133. DOI: 10.3797/scipharm.1401-14.


References
1.
Murata Y, Sasaki N, Miyamoto E, Kawashima S . Use of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm. 2000; 50(2):221-6. DOI: 10.1016/s0939-6411(00)00110-7. View

2.
Efentakis M, Buckton G . The effect of erosion and swelling on the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharm Dev Technol. 2002; 7(1):69-77. DOI: 10.1081/pdt-120002232. View

3.
Bodmeier R, Wang J . Microencapsulation of drugs with aqueous colloidal polymer dispersions. J Pharm Sci. 1993; 82(2):191-4. DOI: 10.1002/jps.2600820215. View

4.
Takka S, Acarturk F . Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul. 1999; 16(3):275-90. DOI: 10.1080/026520499289013. View

5.
Draget K, Skjak-Braek G, Smidsrod O . Alginate based new materials. Int J Biol Macromol. 1997; 21(1-2):47-55. DOI: 10.1016/s0141-8130(97)00040-8. View